NCT06706440

Brief Summary

The external pancreatic fistula (EPF) is characterized by the leakage of pancreatic juice outward through an area of skinor through a drainage tube. The leakage of pancreatic juice occurs due to the rupture of the pancreatic duct (PD) caused by the destruction of pancreatic tissue. EPF can cause deterioration in the patient's condition due to the leakage of protein-rich pancreatic juice outward, as well as the increased risk of skin irritation and infection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2024

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

November 20, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 26, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2025

Completed
Last Updated

February 20, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

November 20, 2024

Last Update Submit

February 18, 2025

Conditions

Keywords

ChildrenAcute necrotizing pancreatitisPancreatic fistula

Outcome Measures

Primary Outcomes (1)

  • The duration of pancreatic fistula functioning

    based on testing serum lipase and/or amylase concentrations in drained fluid, imaging results: ultrasound (US), spiral computed tomography (SCT), magnetic resonance imaging (MRI), fistolography

    From the day of surgery to the end of treatment (9 months)

Secondary Outcomes (7)

  • The level of damage to the main pancreatic duct

    From the day of surgery to the end of treatment (9 months)

  • The duration of hospital stay

    From the day of surgery to the end of treatment (9 months)

  • The mortality

    From enrollment to the end of treatment (9 month)

  • The dynamics of the total protein

    From enrollment to the end of treatment (9 month)

  • The effect of the etiologic factor on the duration of the external pancreatic fistula functioning

    From enrollment to the end of treatment (9 month)

  • +2 more secondary outcomes

Study Arms (1)

children with external pancreatic fistula

children who have suffered acute necrotizing pacreatitis and undergone drainage of parapancreatic accumulations, with the development of an external pancreatic fistula

Other: no intervention, observational study

Interventions

Only data will be taken of patient's file.

children with external pancreatic fistula

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

You may qualify if:

  • Patient or legal representative consent
  • External pancreatic fistula
  • Age from 0-18 years
  • Moderate severe (MSAP) or severe acute pancreatitis (SAP) according to Atlanta criteria revisited in 2012
  • Acute Pancreatitis was defined in case of the presence of at least two of the three criteria according to the classification developed by the INSPPIRE (International Study Group of Pediatric Pancreatitis: In Search for a Cure) group: abdominal pain consistent with the diagnostic hypothesis; serum amylase and/or lipase increased by ≥3 times; imaging results typical of AP: abdominal ultrasound and/or contrast-enhanced CT.

You may not qualify if:

  • Mild acute pancreatitis
  • Chronic pancreatitis
  • No consent from patient or legal representative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

Moscow, 129110, Russia

Location

MeSH Terms

Conditions

Pancreatic FistulaPancreatitis, Acute NecrotizingPancreatitis

Interventions

Observation

Condition Hierarchy (Ancestors)

Digestive System FistulaDigestive System DiseasesPancreatic DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Dmitriy А Pyhteev, PhD

    Head of the Department of Pediatric Surgery

    STUDY DIRECTOR
  • Leonid M Elin

    Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2024

First Posted

November 26, 2024

Study Start

November 11, 2024

Primary Completion

January 10, 2025

Study Completion

February 18, 2025

Last Updated

February 20, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

A complete dataset can be provided upon reasoned request

Locations